What does JIm Cramer think about Pacific Biosciences of California (PACB) ? "This is one of the most speculative stocks in the market. I can't tell you to buy it up here. It's moved too much," Cramer told one caller during the Lightning Round of Mad Money Tuesday night.
The company provides "sophisticated genomic analysis systems that deliver insights to resolve complex genetic challenges." This is way above my pay grade so I will just stick to the charts.
In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. I have found over the years that this candlestick pattern is very successful in catching significant tops. Prices are still above the rising 50-day moving average line but times the level of the rising 200-day moving average. I would consider this extended above the 200-day line.
The On-Balance-Volume (OBV) is still bullish as is the Moving Average Convergence Divergence (MACD) oscillator.